Pharmafile Logo
Pharmafocus logo
Advanced Search

Sanofi

Showing 15 posts of 579 posts found.

shutterstock_138095450

New data shows pharma has not cut back on controversial payments to physicians

July 6, 2017
Medical Communications, Sales and Marketing Allergan, Biogen, Celgene, Sanofi, Valeant

Despite increasing controversy arising over the years due to the questionable relationship between physicians and pharma and the money which …

News
sanofi_regeneron

New potential blockbuster RA treatment enters European market

June 27, 2017
Sales and Marketing AbbVie, Humria, Kevzara, Regeneron, Sanofi

The world’s biggest selling drug, AbbVie’s Humira with $16 billion in sales last year, has a new rival in the …

News

Sanofi and Regeneron posts positive Praluent cholesterol data

June 12, 2017
Research and Development, Sales and Marketing Regeneron, Sanofi, praluent

Sanofi and Regeneron were able to update its PCSK9 therapy Praluent with the positive data showing it could reduce levels …

News

NICE U-turns to recommend Sanofi Gaucher disease drug

June 2, 2017
Medical Communications, Sales and Marketing Gaucher disease, NICE, Sanofi

It has been revealed that NICE has reached the decision to recommend Sanofi’s Cerdelga (eligustat) for use on the NHS …

News
sanofi_hq_reception_close

EMA’s CHMP recommends Sanofi’s Humalog biosimilar

May 22, 2017
Manufacturing and Production, Sales and Marketing Eli Lilly, Humalog, Sanofi

Sanofi has received a positive recommendation by the CHMP for its biosimilar to Eli Lilly’s Humalog. The recommendation for approval …

News
sanofi_new_paris_hq

Sanofi Zika vaccine deal causes controversy

May 22, 2017
Sales and Marketing Sanofi, US army, Zika

In a further twist to Sanofi’s deal with the US Army to develop a vaccine for the Zika virus, the …

News
sanofi_hq_reception_close

Sanofi joins growing list of companies making pricing commitments

May 10, 2017
Medical Communications, Research and Development Sanofi, pricing, transparency

Sanofi has entered an ever-growing list of pharmaceutical companies that are pledging to limit the levels of their price increases …

News
shutterstock_92671375

Sanofi launches lawsuit against Mylan over “illegal business practices”

April 26, 2017
Research and Development, Sales and Marketing Auvi-Q, Mylan, Sanofi, epipen, lawsuit

In a move that is sure to pile even more pressure onto Mylan after the company’s recent woes, Sanofi has …

News
shutterstock_254160583

Sanofi to pay $20m fine for overcharging US veterans

April 4, 2017
Manufacturing and Production, Sales and Marketing Sanofi, Sanofi Pasteur, US

Sanofi Pasteur, the French firm’s vaccines unit, has agreed to pay a $19.8 million settlement over claims it overcharged the …

News

FDA approves first-ever atopic dermatitis biologic treatment

March 31, 2017
Medical Communications, Sales and Marketing Dupixent, Regeneron, Sanofi, atopic dermatitis, biologic

Sanofi and Regeneron’s Dupixent (dupilumab) has become the first biologic medicine to be approved by the FDA for the treatment …

News
sanofi_regeneron

Breakthrough eczema drug given FDA approval

March 29, 2017
Research and Development, Sales and Marketing Dupixent, Regeneron, Sanofi

Regeneron and Sanofi have received approval for its eczema treatment, Dupixent, by the FDA. The treatment will be the first …

News

Sanofi looks to close $1 billion deal Flexion

March 24, 2017
Medical Communications, Sales and Marketing Sanofi, flexion therapeutics, osteo

According to reports emerging, Sanofi may be on the verge of closing a deal with Burlington-based biotech, Flexion Therapeutics. The …

News
pakistan-895319_960_720

Pakistan’s problem with diabetes – with 7 million diabetics

March 20, 2017
Medical Communications, Sales and Marketing Pakistan, Sanofi, diabetes

Pakistan is facing an increasing problem with people suffering from diabetes. At a recent conference, the 4th International Diabetes Conference, …

News
sanofi_new_paris_hq

Patients in UK to be given early access to Sanofi’s eczema treatment

March 14, 2017
Research and Development, Sales and Marketing Dupilumab, MHRA, Sanofi

Sanofi’s treatment for atopic dermatitis, otherwise known as eczema, has been given a positive scientific opinion through the MHRA’s Early …

News

Sanofi and Lonza partner up for €270m biologics facility

February 28, 2017
Manufacturing and Production Lonza, Sanofi

Sanofi and Lonza have announced they are to join forces in a strategic partnership which will see the establishment of …

News
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025